Phase I/II adaptive dose-finding design for combination studies. Several methods are proposed depending on the type of combinations: (1) the combination of two cytotoxic agents, and (2) combination of a molecularly targeted agent with a cytotoxic agent.
|Author||Marie-Karelle Riviere and Jacques-Henri Jourdan|
|Date of publication||2017-05-22 11:44:07 UTC|
|Maintainer||Marie-Karelle Riviere <[email protected]>|
|Package repository||View on CRAN|
Install the latest version of this package by entering the following in R:
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.